Lanadelumab for preventing recurrent attacks of hereditary angioedema

Supporting evidence

• Evaluation report

• Final appraisal determination committee papers  (PDF 941 KB)

  Published:

  16 October 2019

• Appraisal consultation committee papers (PDF 3.63 MB)

  Published:

  16 October 2019